MIP and tuberculosis: Mycobacterium indicus pranii (MIP) is a progenitor of M. avium complex, sharing cross-reactive antigens with M.tb and M. leprae. Studies in mouse and guinea pig models of TB have shown that prophylactic or therapeutic administration of MIP leads to significant reduction in bacillary burden.